News and Events
TOPIC
IBBIS and Concordia AI convene closed door workshop at WAIC in Shanghai
At the World AI Conference in Shanghai, IBBIS and Concordia AI held a closed-door workshop on how AI is reshaping biosecurity risk and governance.
Uncategorized
-
July 16, 2026
Major Updates to the Global DNA Synthesis Map
IBBIS has published the 2026 Report, country-level pages, and a tiered data access portal, expanding what the Global DNA Synthesis Map reveals about the field.
Global Synthesis Map
-
June 11, 2026
IBBIS Granted Category A Liaison Status with ISO Technical Committee 276 (Biotechnology)
IBBIS announces that it has been granted Category A Liaison status with ISO Technical Committee 276
International Standards
-
May 20, 2026
2025 Annual Letter from the Executive Director
IBBIS progress and accomplishments in 2025: a year in review and the path forward
Blog
-
April 21, 2026
Interview with Dr. Shen Yue on her participation in the DSSC China Workstream
Meet the DSSC China Workstream: Dr. Yue Shen on Biosecurity, ISO Standards, and China's Role in Synthetic Biology
Blog
-
April 13, 2026
SIAT Educational Use of the Commec
SIAT uses commec in an innovative educational approach to train future biotechnologists in DNA synthesis screening and biosecurity practices.
Blog
-
March 26, 2026
How Dynegene Approaches DNA Synthesis Screening in a Global Market
Dynegene operates in the highly regulated US and Chinese bioeconomy markets, using commec to meet biosecurity screening requirements in both regions.
Blog
-
March 18, 2026
IBBIS Participates in an EU Commission Workshop
IBBIS was proud to participate in a European Commission workshop on the biosecurity provisions of the proposed European Biotech Act.
Events
-
February 26, 2026
IBBIS Welcomes the Republic of Korea’s National AI-Bio Strategy
IBBIS Welcomes the Republic of Korea's National AI-Bio Strategy, Positioning Korea as a Global Leader in AI-Applied Biotechnology
International Standards
-
January 6, 2026
Translating Customer Screening Guidance into Practical Tools
A new preprint, Implementing Emerging Customer Screening Standards for Nucleic Acid Synthesis, and recommendations to strengthen KYC.
Blog
-
December 17, 2025
IBBIS Launches the Global DNA Synthesis Map at the Biological Weapons Convention
At the Biological Weapons Convention, IBBIS launched the Global DNA Synthesis Map, the first public overview of where synthetic DNA is made, screened, and governed.
Global Synthesis Map
-
December 9, 2025
IBBIS Signs INHR Recommendations on AIxBIO Risks
IBBIS endorses INHR recommendations to governments on mitigating AIxBIO risks
Blog
-
December 1, 2025